investordatabase.org

Sanderling Ventures

sanderling.com Direct investor

Sanderling Ventures is an investment firm founded in 1979 that focuses on building new biomedical companies through early-stage financing and active management. It specializes in areas such as small molecule therapeutics, biologics, drug delivery, platform technologies, and medical devices.

Sanderling Ventures is a venture capital firm headquartered in San Mateo, United States, founded in 1979. It invests directly in companies, from seed to Series C and later, in biomedical, small molecule therapeutics, biologics and vaccines and drug delivery. 90 portfolio companies, as it reports.

“Dedicated to early-stage biomedical financing and active management”

Sanderling Ventures, own website
Layer
Direct investor
Type
Venture capital
Stage
SeedSeries C+
Headquarters
San Mateo, United States
Sectors
biomedical, small molecule therapeutics, biologics and vaccines, drug delivery, platform technologies, medical devices
Founded
1979
Portfolio
90 companies

Team, as Sanderling Ventures publishes it

  • Fred Middleton Managing Director
  • Timothy Mills Managing Director
  • Michael Dixon Principal
  • Timothy Wollaeger Managing Director Emeritus
  • Pierre Beauparlant Venture Partner
  • Peter McWilliams Venture Partner
  • Benjamin McGraw III Venture Partner
  • Paulette Taylor General Counsel & Principal
  • Robert G. McNeil Founding Partner

Names and roles exactly as listed on sanderling.com. Nothing else about these people is recorded.

Co-invests most often with

Derived from portfolio pages both investors publish themselves: each pair below lists at least one company in common. 32 co-investors found.

and 22 more — the graph.

Where this comes from

Every fact above was read from a page Sanderling Ventures publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 4036 · added 2026-09-03 · link last verified 2026-09-06 · confidence high

Similar investors

Listed under